Provided by Tiger Trade Technology Pte. Ltd.

INNOVENT BIO

101.800
-2.000-1.93%
Volume:4.44M
Turnover:453.74M
Market Cap:177.54B
PE:185.69
High:103.800
Open:103.800
Low:100.900
Close:103.800
52wk High:112.700
52wk Low:69.550
Shares:1.74B
HK Float Shares:1.74B
Volume Ratio:0.51
T/O Rate:0.25%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.548
ROE:7.01%
ROA:2.10%
PB:7.34
PE(LYR):185.69
PS:9.69

Loading ...

Stock Track | INNOVENT BIO Soars 6.95% Intraday on $10.5 Billion Global Oncology Collaboration with Pfizer

Stock Track
·
May 29

Movement Alert|Innovent Biologics Rises 9.15% in Regular Trading, Signs $10.5 Billion Global Strategic Partnership with Pfizer

Market Focus
·
May 29

Innovent Strikes Up to US$10.5 Billion Global Oncology Pact With Pfizer

TIPRANKS
·
May 29

China and US Agree in Principle to Discuss Reciprocal Tariff Reduction Framework; State Council Issues Urban Renewal 15th Five-Year Plan

Stock News
·
May 29

China's Innovent Biologics, Pfizer strike up to $10.5 billion cancer drug deal

Reuters
·
May 29

Pfizer, Innovent Sign Licensing Deal to Develop 12 Cancer Drugs

Dow Jones
·
May 29

BRIEF-Pfizer And Innovent Biologics Enter Global Strategic Collaboration To Accelerate Development Of Innovative Oncology Medicines

Reuters
·
May 29

Innovent signs up to US$10.50 billion global oncology pact with Pfizer

Bulletin Express
·
May 29

Pfizer - and Innovent Enter Global Licensing and Collaboration for 12 Cancer Medicines

THOMSON REUTERS
·
May 29

Pfizer - Innovent to Receive $650 Mln Upfront and up to $9.85 Bln in Milestones

THOMSON REUTERS
·
May 29

INNOVENT BIO (01801) and Pfizer Forge Global Strategic Alliance to Expedite Novel Oncology Drug Development

Stock News
·
May 29

Innovent partners with Pfizer in oncology R&D deal worth up to USD 10.5 billion

Reuters
·
May 29

Innovent Biologics - to Receive $650 Mln Upfront, Deal Value up to $10.5 Bln

THOMSON REUTERS
·
May 29

Innovent Biologics - Enters Global Strategic Collaboration With Pfizer for 12 Oncology Programs

THOMSON REUTERS
·
May 29

Innovent Biologics - to Receive up to Double-Digit Royalties on Sales of Approved Products

THOMSON REUTERS
·
May 29

Innovative Drug Stocks Decline in Hong Kong Amid Rate Hike Expectations and ASCO Conference Focus

Stock News
·
May 28

Stock Track | Innovent Biologics Plummets 5% Intraday Amid Biotech Sector Sell-off and Capital Allocation Controversy

Stock Track
·
May 28

Movement Alert|Innovent Biologics Falls 3.17% in Regular Trading, Biotech Sector Sell-off Compounded by Capital Allocation Controversy

Market Focus
·
May 28

BlackRock Boosts Stake in Innovent Bio with Additional HK$30 Million Purchase

Stock News
·
May 27

Innovent Biologics Cancer Updates Test Investor Confidence In Undervalued Shares

Simply Wall St.
·
May 24